Brochure
1 Oct 2020

Cerbios offers high quality tailor-made programs for biopharmaceuticals

PDF 707 kB
Download

From cloning to cGMP production, Cerbios meets your product development and manufacturing needs for recombinant proteins, monoclonal antibodies (mAbs) and novel mAbs derivatives including fragments and Bispecific.

Content provided by our supplier

Cerbios-Pharma SA

  • CH
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Custom Manufacturing/Custom Synthesis
Generic APIs producer
View company profile

Other Content from Cerbios-Pharma SA (4)

  • Cerbios FDF based on probiotic strain SF68

    Brochure Cerbios FDF based on probiotic strain SF68

    Cerbios own and manufactures the strain Enterococcus lactis SF68 applied in different therapeutic areas:

    - Diarrhea, travellers diarrhea and dysbiosis: drug with 20 clinical trials, CTD dossier and registration from Switzerland (for extra EU Countries)


    - Acne & Seborrheic dermatitis
    - Obesity/Cholesterol and metabiolic syndrome
    - IBS
    - Immunity Booster


    Any product is supported by precilical and clinical evidences.


    Cerbios business model if B2B, searching for commercial Licensees worldwide





  • High Potency Active Ingredients CDMO Services

    Brochure High Potency Active Ingredients CDMO Services

    Cerbios is highly qualified in process development of new APIs and HPAPIs for preclinical, clinical and commercial supply. Cerbios is the ideal and reliable partner for your New Chemical Entity (NCE), NDA submission and commercial manufacturing.
  • ADCs Toxin and Conjugation CDMO Services

    Brochure ADCs Toxin and Conjugation CDMO Services

    Offered Services: Process and Analytical Development cGMP Manufacturing in the Fully Integrated site of Lugano Complete Regulatory Documentation for IND submission and NDA Commercial Supply
  • Company video

    Brochure Company video